Mr. Lev Gerlovin has more than 15 years of consulting experience across strategic planning, litigation, and policy spheres. His recent focus has been in leading strategy and litigation engagements for a diverse set of clients, including leading pharmaceutical and biotechnology manufacturers, distributors, health plan providers, and industry groups.
Mr. Gerlovin has managed projects spanning product design and optimization, launch strategy, pricing and market access, portfolio lifecycle management, channels and distribution, sales and marketing effectiveness, and organizational design in business strategy cases, and liabilities and monetary damages assessment in litigation cases. He has broad therapeutic category experience, particularly in neurology, endocrinology, central nervous system, infectious diseases, oncology, rheumatology, and nuclear medicine. Mr. Gerlovin is a Chartered Financial Analyst.
MBA and MS Finance, Boston College
BA magna cum laude, Economics, Harvard College